經導管心臟瓣膜置換術市場規模、佔有率和成長分析（按產品、手術方法、最終用途、應用和地區分類）－2026-2033年產業預測

預計到 2024 年，經導管心臟瓣膜置換市場規模將達到 75 億美元，到 2025 年將達到 86 億美元，到 2033 年將達到 257.8 億美元，在預測期（2026-2033 年）內，複合年成長率為 14.7%。

經導管心臟瓣膜置換術市場經歷了顯著成長，它已成為傳統開胸手術的替代方案，尤其適用於重度主動脈瓣疾病患者。經導管主動脈瓣置換術術（TAVR）等手術透過導管植入人工瓣膜，具有許多優勢，包括降低手術風險、縮短住院時間和加快復健速度。這種方法對高風險患者和以往被認為不適合手術的患者尤其有利。市場成長的主要促進因素包括技術創新、患者群體不斷擴大以及醫療專業人員對該技術的接受度不斷提高。人口老化和心血管疾病發生率的上升進一步推動了對TAVR的需求。製造商持續加大研發投入，旨在改善瓣膜設計和手術流程，最終改善心血管疾病患者的治療效果和生活品質。

推動經導管心臟瓣膜置換市場發展的因素

瓣膜性心臟病，尤其是主動脈瓣狹窄的盛行率不斷上升，受到全球人口老化的顯著影響，導致經導管心臟瓣膜置換術（THVR）的需求增加。隨著老齡化，人們罹患瓣膜相關疾病的風險也隨之增加，因此尋求THVR治療的患者人數也隨之增加。這種人口結構的變化不僅增加了瓣膜性心臟病的發生率，也凸顯了對高效、微創治療方法（如THVR）的需求，從而重塑了這些先進心臟手術的市場格局。因此，THVR的需求正在上升，反映了這些社會趨勢。

經導管心臟瓣膜置換市場的阻礙因素

經導管心臟瓣膜置換術市場面臨諸多限制因素，主要源自於此類手術的高前期成本。器械及所需專用設備的費用可能相當可觀，這阻礙了醫療機構採用這些技術。此外，健保報銷政策的不一致和地區監管差異也會造成財務上的複雜性，最終限制患者獲得這些先進療法的機會。這些因素共同構成了阻礙經導管心臟瓣膜置換術解決方案在醫療市場發展和廣泛應用的挑戰。

經導管心臟瓣膜置換市場市場趨勢

經導管心臟瓣膜置換術（THVR）市場正經歷著動態的變革，其特點是科技的快速發展正在改變患者照護。先進的瓣膜設計、尖端的成像技術以及改進的輸送機制的出現，使得手術更加有效且創傷更小。這些創新不僅最大限度地降低了風險和併發症，還擴大了適用患者群體。因此，THVR 越來越受到青睞，逐漸取代了傳統的外科手術，並迅速重塑了主動脈瓣疾病的治療模式。這推動了市場擴張，並促進了全球醫療機構對該技術的廣泛應用。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球經導管心臟瓣膜置換術市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 經導管肺動脈瓣置換術
• 經導管二尖瓣瓣膜修復與置換術
• 經導管主動脈瓣置換術

全球經導管心臟瓣膜置換術市場規模（按手術方式和複合年成長率分類）（2026-2033 年）

• 經心尖入路
• 經股骨入路
• 其他

全球經導管心臟瓣膜置換術市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 導管檢查室
• 醫院

全球經導管心臟瓣膜置換術市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 肺動脈瓣膜疾病
• 二尖瓣疾病
• 主動脈瓣疾病

全球經導管心臟瓣膜置換術市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Edwards Lifesciences Corporation（USA）
• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• JenaValve Technology, Inc.（USA）
• SYMETIS（Switzerland）
• Braile Biomedica（Brazil）
• CryoLife, Inc.（USA）
• Micro Interventional Devices, Inc.（USA）
• LivaNova PLC（UK）
• Meril Life Sciences Pvt. Ltd.（India）
• Venus Medtech（Hangzhou）Inc.（China）
• Suzhou Jiecheng Medical Technology Co. Ltd.（China）
• Peijia Medical Limited（China）
• Blue Sail Medical Co., Ltd.（China）
• Colibri Heart Valve LLC（USA）
• HighLife SAS（France）
• Neovasc Inc.（Canada）
• St. Jude Medical, Inc.（USA）

結論與建議

Transcatheter Heart Valve Replacement Market size was valued at USD 7.5 Billion in 2024 and is poised to grow from USD 8.6 Billion in 2025 to USD 25.78 Billion by 2033, growing at a CAGR of 14.7% during the forecast period (2026-2033).

The transcatheter heart valve replacement market is experiencing significant growth as it emerges as a preferred alternative to traditional open-heart surgery, particularly for patients with severe aortic valve disease. With procedures like TAVR, which involves implanting a prosthetic valve through catheterization, significant benefits include reduced surgical risks, shorter hospital stays, and faster recovery times. This approach is especially valuable for high-risk or previously inoperable patients. Key drivers of market expansion include technological innovations, a widening patient demographic, and increased acceptance among healthcare practitioners. The aging population and heightened incidence of cardiovascular conditions further amplify demand for TAVR. Continuous investment in research and development from manufacturers aims to enhance valve designs and procedural techniques, ultimately promising improved patient outcomes and quality of life in cardiovascular care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Transcatheter Heart Valve Replacement market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Transcatheter Heart Valve Replacement Market Segments Analysis

Global Transcatheter Heart Valve Replacement Market is segmented by product, surgical approach, end-use, application and region. Based on product, the market is segmented into transcatheter pulmonary valve replacement, transcatheter mitral valve repair & replacement and transcatheter aortic valve replacement. Based on surgical approach, the market is segmented into transapical approach, transfemoral approach and others. Based on end-use, the market is segmented into cath labs and hospitals. Based on application, the market is segmented into pulmonary valvular heart disease, mitral valvular heart disease and aortic valvular heart disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Transcatheter Heart Valve Replacement Market

The growing prevalence of heart valve diseases, particularly aortic stenosis, is significantly influenced by the aging population worldwide, leading to heightened demand for transcatheter heart valve replacement (THVR). As individuals age, they are more susceptible to developing valve-related conditions, which in turn expands the number of patients seeking THVR interventions. This demographic shift toward an older population not only increases the incidence of heart valve issues but also emphasizes the need for effective, minimally invasive solutions such as THVR, ultimately shaping the market landscape for these advanced cardiac treatments. The demand for THVR is thus on the rise, reflecting these societal trends.

Restraints in the Transcatheter Heart Valve Replacement Market

The Transcatheter Heart Valve Replacement market faces several constraints, primarily due to the high initial costs involved in these procedures. The expenses related to the devices and the necessary specialized equipment can be significant, which may deter healthcare providers from adopting these technologies. Furthermore, inconsistencies in reimbursement policies and varying regulations across different regions can complicate the financial aspects, ultimately limiting patient access to these advanced treatments. These factors collectively pose challenges that may impede the growth and wider acceptance of transcatheter heart valve replacement solutions in the healthcare market.

Market Trends of the Transcatheter Heart Valve Replacement Market

The Transcatheter Heart Valve Replacement (THVR) market is experiencing a dynamic evolution characterized by rapid technological advancements that are transforming patient care. The emergence of sophisticated valve designs, cutting-edge imaging modalities, and enhanced delivery mechanisms is facilitating more effective and less invasive procedures. These innovations are not only minimizing risks and complications but also broadening the demographic of patients eligible for treatment. Consequently, the growing preference for THVR over traditional surgical options is rapidly reshaping treatment paradigms for aortic valve diseases, propelling market expansion and fostering increased adoption among healthcare providers globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Transcatheter Heart Valve Replacement Market Size by Product & CAGR (2026-2033)

• Market Overview
• Transcatheter Pulmonary Valve Replacement
• Transcatheter Mitral Valve Repair & Replacement
• Transcatheter Aortic Valve Replacement

Global Transcatheter Heart Valve Replacement Market Size by Surgical Approach & CAGR (2026-2033)

• Market Overview
• Transapical Approach
• Transfemoral Approach
• Others

Global Transcatheter Heart Valve Replacement Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Cath Labs
• Hospitals

Global Transcatheter Heart Valve Replacement Market Size by Application & CAGR (2026-2033)

• Market Overview
• Pulmonary Valvular Heart Disease
• Mitral Valvular Heart Disease
• Aortic Valvular Heart Disease

Global Transcatheter Heart Valve Replacement Market Size & CAGR (2026-2033)

• North America (Product, Surgical Approach, End-Use, Application)
  • US
  • Canada
• Europe (Product, Surgical Approach, End-Use, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Surgical Approach, End-Use, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Surgical Approach, End-Use, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Surgical Approach, End-Use, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYMETIS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micro Interventional Devices, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (Hangzhou) Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Suzhou Jiecheng Medical Technology Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peijia Medical Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Blue Sail Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HighLife SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovasc Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations